A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Extends whistleblower protections to employees of contractors, subcontractors, or grantees of elements of the intelligence community who disclose information regarding such an element, or its activities, if the employee complies with procedures to report urgent concerns to Congress by first submitting the information to an appropriate agency Inspector General under the Central Intelligence Agency Act of 1949 or the Inspector General Act of 1978. (Currently, employees of contractors of the intelligence community are excluded from certain whistleblower protections that are provided to employees of contractors of the Department of Defense and other federal agencies.) Requires courts that receive a disclosure of information required by executive order to be kept classified (in the interests of national defense or the conduct of foreign affairs) to treat the information in a manner consistent with the interests of the national security of the United States, including through the use of summaries or ex parte submissions if the element of the intelligence community concerned advises the court that such procedures are warranted.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2019 · second_quarter · Health Issues
The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico Legislation to increase transparency in the prior authorization process Efforts to educate legislators about un-intended consequences associated with rate setting for health care services
Read twice and referred to the Select Committee on Intelligence.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $217,045 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2019 · first_quarter · Health Issues
The Resident Education Deferred Interest Act (HR 1554) FY2020 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2143) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $210,934 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2018 · fourth_quarter · Health Issues
The Resident Education Deferred Interest Act (HR 5734) FY2019 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $189,038 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2018 · fourth_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Protecting Access to Medicare Act Issues related to diagnostics payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act of 2018 S. 2891 related to the expansion of the Sunshine program
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
FY2019 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $189,038 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2018 · third_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the development of Medicare payments for telehealth and remote monitoring services H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Protecting Access to Medicare Act Issues related to diagnostics payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act of 2018 S. 2891 related to the expansion of the Sunshine program
Client expense: $700,000 · Firm income: Not reported
2018 · third_quarter · Health Issues
FY2019 LHHS Appropriations bill-funding for NIH/NCI HR 4675, Low Dose Radiation Research Act Access to radioactive isotopes Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $197,287 · Firm income: Not reported
2018 · second_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Protecting Access to Medicare Act Issues related to diagnostics payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act of 2018 S. 2891 related to the expansion of the Sunshine program
Client expense: $740,386 · Firm income: Not reported
2018 · second_quarter · Health Issues
Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $235,969 · Firm income: Not reported
2018 · first_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to diagnostics payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act of 2018
Client expense: $1,050,000 · Firm income: Not reported
2018 · first_quarter · Health Issues
Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Initiative Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $174,676 · Firm income: Not reported
2017 · fourth_quarter · Medicare/Medicaid
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Patient Access to Medicare Protection Act H.R. 4679 "Ensuring Equal Access to Treatments Act of 2017 H.R. 4683 related to NTAP Medicare payments
Client expense: $1,010,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $146,734 · Firm income: Not reported
2017 · third_quarter · Health Issues
Support for a national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment Oppose Graham-Cassidy Amendment Support Children's Health Insurance Re authorization Act Support Medicare Red Tape Supplemental Appropriations for Disaster Relief for Puerto Rico
Client expense: $88,649 · Firm income: Not reported
2017 · third_quarter · Medicare/Medicaid
Issues related to physician owned distributors of devices Issues related to deficit reduction and Medicare Issues related to value-based healthcare and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act H.R. 3635, S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Patient Access to Medicare Protection Act ID
Client expense: $760,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Medicare/Medicaid
Issues related to physician owned distributors of devices Issues related to deficit reduction and Medicare Issues related to value-based healthcare and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to Patient Access to Medicare Protection Act ID
Client expense: $760,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Health Issues
Support for a national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, Oppose American Health Care Act and Senate Better Care Reconciliation Amendment
Client expense: $384,364 · Firm income: Not reported
2017 · first_quarter · Medicare/Medicaid
Issues related to physician owned distributors of devices Issues related to deficit reduction and Medicare Issues related to Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and Bundling Issues related to the CMS program for durable medical equipment Issues related to the development of Medicare payments for telehealth and remote monitoring services Issues related to applying the unique device identifier to Medicare claims forms S. 787 Telehealth Innovation and Improvement Act Issues related to Ensuring Access to Critical Breakthrough Products Act S. 794 Local Coverage Determination Clarification Act of 2016 Issues related to physician payment disclosure
Client expense: $1,070,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Health Issues
Support for a national reporting database of medical errors related to the delivery of radiation therapy. Support for the development of an appropriate medical event definition. Support to ensure that patient care advances in biomedical research impacting patient care are not compromised by any policies imposed on the medical use and research applications of cesium chloride. Support for NRC Commissioner nominee to have medical background. Support patient choice in treatment options by closing the in-office ancillary services exception to the Stark Law for radiation oncology services; Protecting Integrity in Medicare Act (H.R. 2066) Oppose Non-Burning Sunshine Report Language Oppose HR 1150, Tanning Tax Repeal Act of 2017 Radiation Oncology reimbursement Radiation Oncology safety Cancer Moonshot Initiative S. 794 Local Coverage Determination Clarification Act of 2016 HR 1629, American Health Care Act
Client expense: $166,498 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
2016 · first_quarter · Government Issues
VA Patient Protection Act of 2015(S.2291) Dr. Chris Kirkpatrick Whistleblower Protection Act of 2015(S.2127) A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community (S.794) A bill to enhance whistleblower protection for contractor and grantee employees (S.795) Legal Justice for Servicemembers Act of 2015 (S.1130) *DHS Insider Threat and Mitigation Act (H.R. 3361) *Thoroughly Investigating Retaliation Against Whistleblowers Act (H.R. 4639) *The Inspector General Empowerment Act of 2015 (S. 579)
Client expense: $14,300 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Government Issues
VA Patient Protection Act of 2015(S.2291) Dr. Chris Kirkpatrick Whistleblower Protection Act of 2015(S.2127) A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community (S.794) A bill to enhance whistleblower protection for contractor and grantee employees (S.795) Legal Justice for Servicemembers Act of 2015 (S.1130) Defend Trade Secrets Act of 2015 (S.1890)
Client expense: $14,286 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Government Issues
Veterans Affairs Retaliation Prevention Act of 2015 (H.R. 571) VA Accountability Act (H.R. 1994) Federal Employee Antidiscrimination Act of 2015 (H.R. 1557) A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community (S. 794) Legal Justice for Servicemembers Act of 2015 (S. 1130)
Client expense: $14,286 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Government Issues
Intelligence Authorization Act for FY 2016 (H.R. 2596) Veterans Affairs Retaliation Prevention Act of 2015 (H.R. 571) A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community (S. 794) Legal Justice for Servicemembers Act of 2015 (S. 1130)
Client expense: $14,286 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2015 · second_quarter · Government Issues
Intelligence Authorization Act for FY 2016 (H.R. 2596) Veterans Affairs Retaliation Prevention Act of 2015 (H.R. 571) A bill to extend whistleblower protections for defense contractor employees to employees of contractors of the elements of the intelligence community (S. 794) Legal Justice for Service members Act of 2015 (S. 1130)
Client expense: $14,287 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), Office of Management & Budget (OMB), SENATE